Related references
Note: Only part of the references are listed.Charcot-Leyden crystals promote neutrophilic inflammation in patients with nasal polyposis
Elien Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Contributions of Eosinophils to Human Health and Disease
Amy D. Klion et al.
Annual Review of Pathology-Mechanisms of Disease (2020)
Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin
Tetsuji Takabayashi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Increased CD69 expression on activated eosinophils in eosinophilic chronic rhinosinusitis correlates with clinical findings
Yasutaka Yun et al.
ALLERGOLOGY INTERNATIONAL (2020)
Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps
Rory Chan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity
Takeshi Tsuda et al.
INTERNATIONAL IMMUNOLOGY (2019)
Protein crystallization promotes type 2 immunity and is reversible by antibody treatment
Emma K. Persson et al.
SCIENCE (2019)
Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis
Whitney W. Stevens et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Charcot-Leyden crystal protein/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma
Sharmilee M. Nyenhuis et al.
BIOMARKERS IN MEDICINE (2019)
Eosinophil extracellular trap formation is closely associated with disease severity in chronic rhinosinusitis regardless of nasal polyp status
Chi Sang Hwang et al.
SCIENTIFIC REPORTS (2019)
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
Claus Bachert et al.
LANCET (2019)
OMALIZUMAB EFFICACY AND SAFETY IN NASAL POLYPOSIS: RESULTS FROM TWO PARALLEL, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS
P. Gevaert et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
Increased expression of L-plastin in nasal polyp of patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease
Tetsuji Takabayashi et al.
ALLERGY (2019)
Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis
Karin Jonstam et al.
ALLERGY (2019)
Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies
Fanny Legrand et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size
Tanya M. Laidlaw et al.
LARYNGOSCOPE (2019)
Changes in the clinical and histological characteristics of Chinese chronic rhinosinusitis with nasal polyps over 11 years
Weiqing Wang et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2019)
Comparison of Corticosteroids by 3 Approaches to the Treatment of Chronic Rhinosinusitis With Nasal Polyps
Yunyun Zhang et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2019)
AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice
Bradford A. Youngblood et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes
Sandhya R. Panch et al.
BLOOD (2018)
A Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Phase 1 Study of AK002, a Novel Siglec-8 Selective Monoclonal Antibody, in Healthy Subjects
Henrik S. Rasmussen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease
Hiam Abdala-Valencia et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma
Eugene R. Bleecker et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
High tissue eosinophilia as a marker to predict recurrence for eosinophilic chronic rhinosinusitis: a systematic review and meta-analysis
Tobial McHugh et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2018)
Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement
Hongfei Lou et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2018)
The prognostic role of serum eosinophil and basophil levels in sinonasal polyposis
Giuseppe Brescia et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2017)
Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois
Bruce K. Tan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Chronic rhinosinusitis in Asia
Yuan Zhang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
Claus Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation
Elien Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Superior Turbinate Eosinophilia Correlates With Olfactory Deficit in Chronic Rhinosinusitis Patients
Jennifer Lavin et al.
LARYNGOSCOPE (2017)
Role of tissue eosinophils in chronic rhinosinusitis-associated olfactory loss
Leah J. Hauser et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2017)
Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis
Alexander Rivero et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2017)
The targeted eosinophil-lowering effects of dexpramipexole in clinical studies
Steven I. Dworetzky et al.
BLOOD CELLS MOLECULES AND DISEASES (2017)
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis A Randomized Clinical Trial
Claus Bachert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania
Xiangdong Wang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study
T. Tokunaga et al.
ALLERGY (2015)
Cytokines in Chronic Rhinosinusitis Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease
Whitney W. Stevens et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Tissue factor and tissue factor pathway inhibitor in nasal mucosa and nasal secretions of chronic rhinosinusitis with nasal polyp
Shino Shimizu et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2015)
Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population
Hongfei Lou et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2015)
Pathogenesis of nasal polyposis
K. E. Hulse et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2015)
Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophilia
Mahboobeh Mahdavinia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Inflammatory patterns in upper airway disease in the same geographical area may change over time
Michael Katotomichelakis et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2013)
Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma
Tomoko Tajiri et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2013)
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Changes in Histological Features of Nasal Polyps in a Korean Population over a 17-year Period
Su Jin Kim et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2013)
Eosinophils: changing perspectives in health and disease
Helene F. Rosenberg et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Role of imbalance of eicosanoid pathways and staphylococcal superantigens in chronic rhinosinusitis
R. Pezato et al.
ALLERGY (2012)
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Efficacy of omalizumab in the treatment of nasal polyps
Maria del Carmen Vennera et al.
THORAX (2011)
Mucosal eosinophilia and recurrence of nasal polyps - new classification of chronic rhinosinusitis
Tsuguhisa Nakayama et al.
RHINOLOGY (2011)
Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease
Nan Zhang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
T-cell regulation in chronic paranasal sinus disease
Nicholas Van Bruaene et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Eicosanoid metabolism and eosinophilic inflammation in nasal polyp patients with immune response to Staphylococcus aureus enterotoxins
Claudina Angela Perez-Novo et al.
AMERICAN JOURNAL OF RHINOLOGY (2006)
Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis
CA Pérez-Novo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis
JB Watelet et al.
ALLERGY (2004)
Molecular and cellular staging for the severity of chronic rhinosinusitis
SE Kountakis et al.
LARYNGOSCOPE (2004)
Total and specific IgE in nasal polyps is related to local eosinophilic inflammation
C Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Share Paper
